Bailard’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Bailard’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-29,000	Closed	-$79K	–	597
2019 Q4	$79K	Buy	+29,000	New	+$1.37M	﹤0.01%	530
2018 Q3	–	Sell	-41,000	Closed	-$176K	–	575
2018 Q2	$176K	Sell	41,000 -17,000	-29%	-$731K	0.01%	503
2018 Q1	$99K	Buy	+58,000	New	+$2.26M	0.01%	471

Bailard's ARNA Position: Q1 2022 in Review

Bailard sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 4,200 shares — an estimated $390K sold.

Bailard first reported a position in ARNA in Q4 2017 and held it in 15 quarters. The position peaked at $3.46M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

Bailard reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
Bailard sold 4,200 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $390K.
Bailard first reported a position in Arena Pharmaceuticals Inc in Q4 2017 and held it in 15 quarters.
Bailard's Arena Pharmaceuticals Inc position peaked at $3.46M in Q2 2019.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Bailard's 13F filing for Q1 2022, filed 25 Apr 2022.